Antigentests als ergänzendes Instrument in der Pandemiebekämpfung
Janna Seifried, Martin Mielke, Claudia M. Denkinger(Heidelberg University), Esther-Maria Antão(Freie Universität Berlin), Karl Broich(Federal Institute for Drugs and Medical Devices), Sindy Böttcher(Robert Koch Institute), Tanja Jung-Sendzik, Mirjam A. Jenny(Max Planck Institute for Human Development), Lars Schaade(Robert Koch Institute), Max von Kleist(Robert Koch Institute), Djin‐Ye Oh(Robert Koch Institute), Osamah Hamouda(Robert Koch Institute), Ralf Bartenschlager(German Cancer Research Center)
Cited by 12
Related Papers
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria
|Alzheimer s & Dementia|2016|1.9k
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras
|Proceedings of the National Academy of Sciences|2006|712
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study
|The Lancet Infectious Diseases|2017|688
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis
|European Respiratory Journal|2014|532